Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and treatment of body dysmorphic disorder in adolescents

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Body dysmorphic disorder (BDD) is an underrecognized and underdiagnosed problem that is relatively common among adolescents. Although the onset of the disorder occurs in adolescence, BDD research in child and adolescent psychiatry is relatively limited. Body dysmorphic disorder has a high rate of co-morbidity with depression and suicide, which indicates important implications for prompt diagnosis and treatment in adolescents with BDD. Effective treatment options include cognitive behavioral therapy (CBT) and pharmacotherapy with serotonin reuptake inhibitors (SRIs). This paper provides a brief overview of BDD in adolescents, presents and evaluates the most recent literature on approaches to diagnosis and treatment, and highlights some of the characteristics that distinguish BDD from other disorders such as obsessive-compulsive disorder, social phobia, depression, and eating disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: APA; 1994.

    Google Scholar 

  2. Albertini RS, Phillips KA: Thirty-three cases of body dysmorphic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:453–459.

    Article  PubMed  CAS  Google Scholar 

  3. Hollander E, Aronowitz B: Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient. J Clin Psychiatry 1999, 60:27–31.

    PubMed  Google Scholar 

  4. Mayville S, Katz R, Gipson M, Cabral K: Assessing the prevalence of body dysmorphic disorder in an ethnically diverse group of adolescents. J Child Fam Stud 1999, 8:357–362.

    Article  Google Scholar 

  5. Phillips KA: Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry 1991, 148:1138–1149.

    PubMed  CAS  Google Scholar 

  6. Sobanski E, Schmidt M: Body dysmorphic disorder: a review of current knowledge. Child Psychol Psychiatry Rev 2000, 5:17–24.

    Article  Google Scholar 

  7. Phillips KA, Atala KD, Pope HG Jr.: Diagnostic instruments for body dysmorphic disorder. Presented at the New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; May 24, 1995; Miami, FL.

  8. Phillips KA, Hollander E, Rasmussen SA, et al.: A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997, 33:17–22.

    PubMed  CAS  Google Scholar 

  9. Phillips KA, Atala KD, Albertini RS: Body dysmorphic disorder in adolescents. J Am Acad Child Adolesc Psychiatry 1995, 34:1216–1220.

    Article  PubMed  CAS  Google Scholar 

  10. Hollander E, Cohen L, Simeon D: Body dysmorphic disorder. Psychiatr Ann 1993, 23:359–364.

    Google Scholar 

  11. Phillips KA, Gunderson CG, Mallya G, et al.: A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry 1998, 59:568–575.

    PubMed  CAS  Google Scholar 

  12. Phillips KA: Body dysmorphic disorder: diagnostic controversies and treatment challenges. Bull Menninger Clin 2000, 64:18–35. This paper provides critical information on recognizing, diagnosing, and treating BDD, and the problems and controversies surrounding these issues. Phillips draws attention to common comorbid disorders and the importance of, and strategies for, treating BDD as a distinct disorder.

    PubMed  CAS  Google Scholar 

  13. Phillips KA, McElroy SL, Keck PE Jr., et al.: Body dysmorphic disorder: thirty cases of imagined ugliness. Am J Psychiatry 1993, 150:302–308.

    PubMed  CAS  Google Scholar 

  14. Phillips KA, McElroy SL, Keck PE Jr., et al.: A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994, 30:179–186.

    PubMed  CAS  Google Scholar 

  15. Phillips KA, Diaz S: Gender differences in body dysmorphic disorder. J Nerv Ment Dis 1997, 185:570–577.

    Article  PubMed  CAS  Google Scholar 

  16. Rosen JC, Ramirez E: A comparison of eating disorders and body dysmorphic disorder on body image and psychological adjustment. J Psychosom Res 1998, 44:441–449. Rosen and Ramirez examine in detail the distinctions in body image between eating disorders and BDD patients. This paper provides similarities and differences between the two disorders, and provides further insight into BDD as a distinct disorder.

    Article  PubMed  CAS  Google Scholar 

  17. Rabe-Jablonska JJ, Sobow TM: The links between body dysmorphic disorder and eating disorders. Eur Psychiatry 2000, 15:302–305.

    Article  Google Scholar 

  18. Phillips KA, Dufresne RG Jr., Wilkel CS, Vittorio CC: Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatology 2000, 42:436–441.

    Article  CAS  Google Scholar 

  19. Andreasen N, Bardach J: Dysmorphophobia: symptom or disease? Am J Psychiatry 1977, 134:673–675.

    PubMed  CAS  Google Scholar 

  20. Grant JE, Kim SW, Crow SJ: Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001, 62:517–522. The authors evaluate the rate of BDD in inpatient psychiatric settings by screening patients specifically for BDD. The authors provide information regarding current problems in diagnosing BDD and implications for treatment of the disorder.

    Article  PubMed  CAS  Google Scholar 

  21. Neziroglu F, McKay D, Todaro J, et al.: Effect of cognitive behavioral therapy on persons with body dysmorphic disorder and comorbid Axis II diagnosis. Behav Ther 1996, 27:67–77.

    Article  Google Scholar 

  22. Neziroglu F, Hsia C, Yaryura-Tobias J: Behavioral, cognitive and family therapy for obsessive-compulsive and related disorders. Psychiatr Clin North Am 2000, 23:657–670.

    Article  PubMed  CAS  Google Scholar 

  23. Neziroglu FA, Yaryrya-Tobias JA: Exposure, response prevention and cognitive therapy in the treatment of body dysmorphic disorder. Behav Ther 1993, 24:431–438.

    Article  Google Scholar 

  24. Wilhelm S, Otto MW, Lohr B, Deckersbach T: Cognitive behavioral therapy for body dysmorphic disorder: a case series. Behav Res Ther 1999, 37:71–75.

    Article  PubMed  CAS  Google Scholar 

  25. McKay D: Two year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif 1999, 23:620–629.

    Article  PubMed  CAS  Google Scholar 

  26. Hollander E, Allen A, Kwon J, et al.: Clomipramine vs. desipramine crossover trial in body dysmorphic disorder. Arch Gen Psychiatry 1999, 56:1033–1039. This paper provides information on effective pharmacological treatment for both delusional and nondelusional BDD. The authors examine the efficacy of an SRI versus a serotonin norepinephrine reuptake inhibitor (SNRI) in the treatment of BDD.

    Article  PubMed  CAS  Google Scholar 

  27. Perugi G, Giannotti D, Di Vaio S, et al.: Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996, 11:247–254.

    Article  PubMed  CAS  Google Scholar 

  28. Phillips KA, Dwight MM, McElroy SL: Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 1998, 59:165–171.

    PubMed  CAS  Google Scholar 

  29. Phillips KA, Albertini M, Siniscalchi MS, et al.: Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry 2001, 62:721–726. A review of the effectiveness of pharmacotherapy in the treatment of BDD. The authors critically review the charts of adult and adolescent patients followed for 2 to 8 years in order to determine the efficacy of SRIs in treating BDD.

    Article  PubMed  CAS  Google Scholar 

  30. Hollander E, Cohen L, Simeon D, et al.: Fluvoxamine treatment of body dysmorphic disorder [letter]. J Clin Psychopharmacol 1994, 14:75–77.

    PubMed  CAS  Google Scholar 

  31. El-Khatib H, Dickey T: Sertraline for body dysmorphic disorder [letter]. J Am Acad Child and Adolescent Psychiatry 1995, 34:1404–1405.

    Article  CAS  Google Scholar 

  32. Hollander E, Liebowitz MR, Winchel R, et al.: Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 1989, 146:768–770.

    PubMed  CAS  Google Scholar 

  33. Phillips KA: Pharmacologic treatment of BDD. Psychopharmacol Bull 1996, 32:597–605.

    PubMed  CAS  Google Scholar 

  34. Phillips KA: Pharmacologic treatment of body dysmorphic disorder: a review of empirical data and a proposed treatment algorithm. Psychiatr Clin North Am 2000, 7:59–82.

    Google Scholar 

  35. Hollander E, Liebowitz M, Winchel R, et al.: Treatment of BDD with serotonin reuptake blockers. Am J Psychiatry 1989, 146:768–770.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Mount Sinai Medical Center, Box 1230, 10029, New York, NY, USA

    Sallie Jo Hadley MD, Jennifer Greenberg BA & Eric Hollander MD

Authors
  1. Sallie Jo Hadley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Greenberg BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Hollander MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hadley, S.J., Greenberg, J. & Hollander, E. Diagnosis and treatment of body dysmorphic disorder in adolescents. Curr Psychiatry Rep 4, 108–113 (2002). https://doi.org/10.1007/s11920-002-0043-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-002-0043-4

Keywords

Search

Navigation